DSwiss (DQWS) Cost of Revenue (2015 - 2026)
DSwiss' (DQWS) quarterly Cost of Revenue came in at $318545.0 in Q1 2026, down 56.84% year-over-year from $738139.0 in Q1 2025, and down 12.13% quarter-over-quarter from $362504.0 in Q4 2025.
Analysis
DSwiss (DQWS) Cost of Revenue (2015 - 2026) Analysis & Trends
DSwiss (DQWS) has reported Cost of Revenue for 12 consecutive years, with $318545.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Cost of Revenue fell 56.84% year-over-year to $318545.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 36.0% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 5.35% from the prior year.
- Cost of Revenue was $318545.0 for Q1 2026 at DSwiss, down from $362504.0 in the prior quarter.
- Over five years, Cost of Revenue peaked at $926945.0 in Q4 2024 and troughed at $183937.0 in Q1 2023.
- A 5-year average of $451734.4 and a median of $362504.0 in 2025 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue sank 66.16% in 2022 and soared 266.34% in 2025, its largest moves.
- Over 5 years, Cost of Revenue stood at $214698.0 in 2022, then surged by 78.08% to $382338.0 in 2023, then soared by 142.44% to $926945.0 in 2024, then sank by 60.89% to $362504.0 in 2025, then dropped by 12.13% to $318545.0 in 2026.
- The last three Cost of Revenue figures came in at $318545.0 (Q1 2026), $362504.0 (Q4 2025), and $383049.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.76 Bn | 69.72 Bn | 3.30 Bn | 2.07 Bn |
| 2 | Kenvue | 35.95 Bn | 34.84 Bn | 2.30 Bn | 1.65 Bn |
| 3 | Kimberly Clark | 34.91 Bn | 34.08 Bn | 1.60 Bn | 2.59 Bn |
| 4 | Bath & Body Works | 3.94 Bn | 3.15 Bn | 692.00 Mn | 822.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.94 Bn | 2.87 Bn | - | - |
| 6 | Perrigo | 2.07 Bn | 1.67 Bn | 313.90 Mn | 708.90 Mn |
| 7 | Edgewell Personal Care | 1.33 Bn | 933.73 Mn | 242.50 Mn | 327.60 Mn |
| 8 | Herbalife | 1.30 Bn | 935.57 Mn | 1.03 Bn | 466.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | DSwiss | 6.21 Mn | 6.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 318,545.00 |
| Dec 31, 2025 | 362,504.00 |
| Sep 30, 2025 | 383,049.00 |
| Jun 30, 2025 | 872,732.00 |
| Mar 31, 2025 | 738,139.00 |
| Dec 31, 2024 | 926,945.00 |
| Sep 30, 2024 | 913,997.00 |
| Jun 30, 2024 | 447,182.00 |
| Mar 31, 2024 | 201,492.00 |
| Dec 31, 2023 | 382,338.00 |
| Sep 30, 2023 | 281,010.00 |
| Jun 30, 2023 | 263,561.00 |
| Mar 31, 2023 | 183,937.00 |
| Dec 31, 2022 | 214,698.00 |
| Sep 30, 2022 | 193,969.00 |
| Jun 30, 2022 | 663,012.00 |
| Mar 31, 2022 | 332,375.00 |
| Dec 31, 2021 | 489,505.00 |
| Sep 30, 2021 | 573,129.00 |
| Jun 30, 2021 | 223,818.00 |